Diagnosis and treatment of cancer using anti-LGR7 antibody

Details for Australian Patent Application No. 2009331178 (hide)

Owner The University of Tokyo Forerunner Pharma Research Co., Ltd.

Inventors Aburatani, Hiroyuki; Uehara, Yuriko; Funahashi, Shinichi

Agent Spruson & Ferguson

Pub. Number AU-A-2009331178

PCT Pub. Number WO2010/074192

Priority 2008-333149 26.12.08 JP

Filing date 25 December 2009

Wipo publication date 1 July 2010

International Classifications

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C12N 15/02 (2006.01) Mutation or genetic engineering - Preparation of hybrid cells by fusion of two or more cells, e.g. protoplast fusion

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

C12P 21/08 (2006.01) Preparation of peptides or proteins - Monoclonal antibodies

Event Publications

11 August 2011 PCT application entered the National Phase

  PCT publication WO2010/074192 Priority application(s): WO2010/074192

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009331179-Novel bicyclic heterocyclic compound

2009331175-Rack assembly